160 related articles for article (PubMed ID: 1318082)
1. Decreased platelet imipramine binding in Tourette syndrome children with obsessive-compulsive disorder.
Weizman A; Mandel A; Barber Y; Weitz R; Cohen A; Mester R; Rehavi M
Biol Psychiatry; 1992 Apr; 31(7):705-11. PubMed ID: 1318082
[TBL] [Abstract][Full Text] [Related]
2. Serotonin uptake and imipramine binding in the blood platelets of obsessive-compulsive disorder patients.
Bastani B; Arora RC; Meltzer HY
Biol Psychiatry; 1991 Jul; 30(2):131-9. PubMed ID: 1655071
[TBL] [Abstract][Full Text] [Related]
3. Platelet 3H-imipramine binding sites in obsessive-compulsive behavior.
Kim SW; Dysken MW; Pandey GN; Davis JM
Biol Psychiatry; 1991 Sep; 30(5):467-74. PubMed ID: 1657222
[TBL] [Abstract][Full Text] [Related]
4. High-affinity imipramine binding and serotonin uptake in platelets of eight adolescent and ten adult obsessive-compulsive patients.
Weizman A; Carmi M; Hermesh H; Shahar A; Apter A; Tyano S; Rehavi M
Am J Psychiatry; 1986 Mar; 143(3):335-9. PubMed ID: 3006522
[TBL] [Abstract][Full Text] [Related]
5. Tritiated imipramine binding in obsessive-compulsive volunteers and psychiatrically normal controls.
Black DW; Kelly M; Myers C; Noyes R
Biol Psychiatry; 1990 Feb; 27(3):319-27. PubMed ID: 2154266
[TBL] [Abstract][Full Text] [Related]
6. A test of the tridimensional personality theory: association with diagnosis and platelet imipramine binding in obsessive-compulsive disorder.
Pfohl B; Black D; Noyes R; Kelley M; Blum N
Biol Psychiatry; 1990 Jul; 28(1):41-6. PubMed ID: 2165423
[TBL] [Abstract][Full Text] [Related]
7. Platelet serotonin transporter in children and adolescents with obsessive-compulsive disorder or Tourette's syndrome.
Sallee FR; Richman H; Beach K; Sethuraman G; Nesbitt L
J Am Acad Child Adolesc Psychiatry; 1996 Dec; 35(12):1647-56. PubMed ID: 8973072
[TBL] [Abstract][Full Text] [Related]
8. Psychopathology and personality characteristics in relation to blood serotonin in Tourette's syndrome and obsessive-compulsive disorder.
Cath DC; Spinhoven P; Landman AD; van Kempen GM
J Psychopharmacol; 2001 Jun; 15(2):111-9. PubMed ID: 11448084
[TBL] [Abstract][Full Text] [Related]
9. Platelet imipramine binding and serotonin uptake in obsessive-compulsive patients.
Vitiello B; Shimon H; Behar D; Stoff D; Bridger WH; Friedman E
Acta Psychiatr Scand; 1991 Jul; 84(1):29-32. PubMed ID: 1927563
[TBL] [Abstract][Full Text] [Related]
10. Whole blood serotonin in juvenile obsessive-compulsive disorder.
Hanna GL; Yuwiler A; Cantwell DP
Biol Psychiatry; 1991 Apr; 29(8):738-44. PubMed ID: 2054448
[TBL] [Abstract][Full Text] [Related]
11. Imipramine binding to platelets of children with attention deficit disorder with hyperactivity.
Weizman A; Bernhout E; Weitz R; Tyano S; Rehavi M
Biol Psychiatry; 1988 Mar; 23(5):491-6. PubMed ID: 2830919
[TBL] [Abstract][Full Text] [Related]
12. Platelet paroxetine binding in major depressive disorder with and without comorbid obsessive-compulsive disorder.
Nelson EC; Sheline YI; Bardgett ME; Jackson JL; Csernansky JG
Psychiatry Res; 1995 Sep; 58(2):117-25. PubMed ID: 8570763
[TBL] [Abstract][Full Text] [Related]
13. Decreased platelet 3H-imipramine binding in Down's syndrome.
Tang SW; Berg JM; Bruni J; Davis A
Psychiatry Res; 1988 Apr; 24(1):67-70. PubMed ID: 2839861
[TBL] [Abstract][Full Text] [Related]
14. Peripheral markers of serotonin and dopamine function in obsessive-compulsive disorder.
Marazziti D; Hollander E; Lensi P; Ravagli S; Cassano GB
Psychiatry Res; 1992 Apr; 42(1):41-51. PubMed ID: 1603880
[TBL] [Abstract][Full Text] [Related]
15. Platelet serotonin uptake and 3H-imipramine binding in panic disorder.
Norman TR; Sartor DM; Judd FK; Burrows GD; Gregory MS; McIntyre IM
J Affect Disord; 1989; 17(1):77-81. PubMed ID: 2544638
[TBL] [Abstract][Full Text] [Related]
16. A family study of juvenile obsessive-compulsive disorder.
Reddy PS; Reddy YC; Srinath S; Khanna S; Sheshadri SP; Girimaji SR
Can J Psychiatry; 2001 May; 46(4):346-51. PubMed ID: 11387791
[TBL] [Abstract][Full Text] [Related]
17. Decreased platelet 3H-paroxetine binding in obsessive-compulsive patients.
Marazziti D; Rossi A; Gemignani A; Giannaccini G; Pfanner C; Milanfranchi A; Presta S; Lucacchini A; Cassano GB
Neuropsychobiology; 1996; 34(4):184-7. PubMed ID: 9121618
[TBL] [Abstract][Full Text] [Related]
18. Platelet serotonergic markers as endophenotypes for obsessive-compulsive disorder.
Delorme R; Betancur C; Callebert J; Chabane N; Laplanche JL; Mouren-Simeoni MC; Launay JM; Leboyer M
Neuropsychopharmacology; 2005 Aug; 30(8):1539-47. PubMed ID: 15886722
[TBL] [Abstract][Full Text] [Related]
19. Conceptual and methodological issues in studies of obsessive-compulsive and Tourette's disorders.
Hollander E; Liebowitz MR; DeCaria CM
Psychiatr Dev; 1989; 7(4):267-96. PubMed ID: 2577300
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the reported association of obsessive-compulsive symptoms or disorder with Tourette's disorder.
Shapiro AK; Shapiro E
Compr Psychiatry; 1992; 33(3):152-65. PubMed ID: 1591906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
